Seeking Alpha

CV Therapeutics Inc. (CVTX)

()

News & PR
Market Currents

Buzz
Twitter: CVTX

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

Fund Clones Q3 2009 Rebalance Update

Dec 3 • AlphaClone • Comment!
Eton Park Loads Up on Options

Sep 2 • Market Folly • 3 Comments
Manikay Partners Buy Healthcare, Dump Financials

Aug 10 • Todd Walker • 1 Comment
Health Care Trends Part 2: M&A, Generic Competition, CROs

Jun 7 • Bullish Bankers • 4 Comments
A Look at M & A Arbitrage Activity

Apr 8 • Jae Jun • Comment!
Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly

Apr 2 • Mark Cifra • 5 Comments
Where Might Genentech Investors Redeploy $47B?

Mar 16 • Michael Becker • 2 Comments
Big Mergers Could Mean Sweet Gains for Biotech

Mar 13 • Smart Profits Report • 6 Comments
Gilead Follows Its Heart, Sweeps CV Away for $1.4B

Mar 13 • EP Vantage • Comment!
Why Is Gilead Buying CV Therapeutics?

Mar 12 • Ockham Research • Comment!
Thursday's Options Recap

Mar 12 • Frederic Ruffy • 1 Comment
CV Tells Astellas to Take a Hike: Looks to Gilead

Mar 12 • Eben Tessari • Comment!
Astellas Announces Offer to Buy CV Therapeutics

Mar 2 • Eben Tessari • Comment!
Know Your Options When Investing in Biotech Stocks

Mar 2 • Zacks.com • 5 Comments
Ugly Stock Stats from an Ugly Bear

Feb 25 • Bespoke Investment Group • 4 Comments
71 Stocks Leading the Nasdaq Higher

Feb 13 • TraderMark • 2 Comments
Bullish Thesis for Biotech Remains Intact

Feb 5 • Michael Becker • 1 Comment
Will CV Therapeutics Get a Higher Price from Astellas?

Jan 27 • Kirk Shinkle • Comment!
Wednesday Options Update: UTX, GE, USB, WMT, NTRS, BK & CVTX

Jan 21 • Andrew Wilkinson • 1 Comment
Looking for the Biotech Breakout

Jan 19 • Jeff Pierce • 5 Comments
New Index of Health Product Innovators

Jan 5 • Mike Havrilla • Comment!
New Emerging Biotech and Pharma Company Index

Nov 23, 2008 • Mike Havrilla • 3 Comments
Rigel Pharmaceuticals: Biotech Crisis or Opportunity?

Nov 10, 2008 • Ohad Hammer • 2 Comments
Thursday Options Update: LVS, CSCO, NWS, CVTX, BAC & WMT

Nov 6, 2008 • Andrew Wilkinson • 1 Comment
'When There's Blood in the Streets', Buy Biotech Stocks

Oct 10, 2008 • Ohad Hammer • 13 Comments
Will M&A Activity Boost PowerShares Dynamic Biotech & Genome ETF?

May 9, 2008 • Don Dion • 1 Comment
Monday's Options Report: BSC, LEH, XLF, ACAS, VIX, CFC, CVTX

Mar 10, 2008 • Andrew Wilkinson • Comment!
Loeb's Third Point Issues Latest 13F: Summary of Holdings

Aug 16, 2007 • Lon Juricic • Comment!
Earnings Preview: Five Companies That Could Surprise

Jul 30, 2007 • Zacks.com • Comment!
Screening for Potential Buyout Targets

Jun 5, 2007 • Mark Hines • 5 Comments
CV Therapeutics: Loeb's Third Point Discloses 9.9% Stake

May 18, 2007 • Lon Juricic • Comment!
Loeb's Third Point Releases 13F Filing, Shows a Number of New Positions

May 17, 2007 • Lon Juricic • Comment!
The Next Great Biotech Short Squeeze

Apr 23, 2007 • Andrew Vaino • Comment!
Biotech Day In Review: Regeneron Up On AMD Data

Mar 28, 2007 • Comment!
Why the CV Therapeutics Sell-off Was Overdone

Mar 9, 2007 • Top Textrader • Comment!
Ranexa Won't Treat Heart Attacks, CV Therapeutics Falls 24%

Mar 8, 2007 • SA Editor Judy Weil • Comment!
Biotech Day in Review: Avalon Signs $200 Million Deal with Merck

Mar 8, 2007 • Centient Biotech Investor • Comment!
CV Therapeutics Trial Results: Enough To Drive Profitability?

Mar 7, 2007 • Notable Calls • Comment!
Will MERLIN Work Magic For CV Therapeutics?

Feb 6, 2007 • Top Textrader • 2 Comments
CV Therapeutics: Last Chance for a Tax Loss

Dec 29, 2006 • Travis Johnson • Comment!
Biotech Portfolio Overview: PDL Biopharm Still Cheap, CV Therapeutics Still Falling

Aug 6, 2006 • Travis Johnson • Comment!

CV Therapeutics Inc. (CVTX)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers